E_mg_GB_03_vorne-29_3_04

More documents

Recommendations

Info

38 Sales Dynamit Nobel in s million 2,460.6 2,328.2 01/02 03 mg CHEMICAL GROUP mg chemical group Dynamit Nobel Dynamit Nobel, which forms part of the chemical group, now concentrates on chemicals and materials technology. This internationally active group supplies innovative specialty products to niche markets in several industrial sectors such as the pharmaceutical, cosmetics, chemical and automotive industries. One of the key technologies and a fast-growing market of the 21st century, with annual growth rates of 15 to 20 percent, is nanotechnology. Dynamit Nobel already earns roughly a20 million from nano-products, which are found in highly effective sun protection creams, automobile paints, wood varnish and UV-protected film for the food and farming industries. One new product to emerge from the research conducted by Sachtleben Chemie, a Duisburg-based subsidiary of Dynamit Nobel, is ‘dirtbusters’. Nano-fine pigments made from titanium dioxide create self-cleaning, dirt-repellent surfaces. The ultra-fine, specially treated titanium-dioxide particles convert light energy into chemical energy. This energy then oxidizes and destroys the dirt, so that the remains can easily be washed off with water. The nano-fine ‘dirtbusters’ are either added to high-quality paints and varnishes or applied directly to the surface as a solution. They are used on house walls, roof tiles and paving stones. Dynamit Nobel’s sales of this pioneering technology are forecast to rise to a35 million by 2006 and to between a60 million and a80 million by 2010. The total volume of mg-relevant markets for nano-products is forecast to be between a500 million and a600 million by 2010. Its business in medical technology based on advanced ceramics has also been highly successful. Dynamit Nobel subsidiary CeramTec is the world’s market leader in the manufacture of ceramic components for artificial hip joints. Roughly 18 percent of CeramTec’s sales stemmed from this fast-growing business in 2003. This amounted to a sales increase of over 30 percent on 2001/2002. Demand for ceramic components in medical equipment is growing rapidly. Ceramics are extremely strong, non-corrosive, very comfortable for patients, and exceptionally hard-wearing. CeramTec expects to see further growth from the U.S. In 2003, the customer to which CeramTec supplies ceramic hip joints won approval from the Federal Drug Administration (FDA), the U.S. healthcare regulator, for ceramic hip joints. In this connection, the company was given approval to supply ceramic couplings to the American market. At present, only six percent of artificial limbs fitted in the U.S. are made of ceramics – they are usually still made of metal. In Germany, by contrast, the proportion is now 60 percent.
MANAGEMENT SHARE STRATEGY SPECIAL SECTION MANAGEMENT REPORT FINANCIAL STATEMENTS FURTHER INFORMATION Clinical trials are now being conducted on artificial knee joints made from the new ceramic material BIOLOX delta. This material makes it possible to manufacture smaller implants and more complex shapes such as knee joints. The plan is to have BIOLOX delta ready to develop a new market by 2006. Dynamit Nobel is also a globally recognized partner to the automotive industry, supplying plastic system components, ceramic components and processes used in the chemical pretreatment of metal parts, including complete car bodies. Chemetall, a Dynamit Nobel subsidiary, developed and brought to market SAM, a new technology that provides environmentally friendly protection against corrosion. ‘SAM’ stands for self-assembling molecules. This technology enables aluminum surfaces to be treated with self-assembling, monomolecular layers and allows manufacturers of car components, for example, to dispense with poisonous additives such as chrome that have traditionally been used. In 2003, Dynamit Nobel generated roughly 37 percent of its total sales from products for the automotive industry. In 2003, technologies produced by this mg subgroup were once again featured in numerous new products on display at the Frankfurt International Motor Show (IAA): these included multifunctional plastic bumper systems and new processes for improving corrosion protection. mg’s customers include all major European carmakers as well as U.S. automotive giants General Motors and Ford. solvadis Part of solvadis’ business involves trading in commodities such as sulfur and methanol. The other part of the business entails distributing chemicals. Distribution involves the speedy and error-free delivery of chemicals in small packing drums, containers, and tank trucks. solvadis also offers a wide spectrum ranging from the storage and distribution of industrial chemicals to the distribution of specialty products. These specialty products include solid chemicals, acids, alkaline solutions, and solvents. The main customers are the pharmaceutical, cosmetics and chemical industries, paint and varnish manufacturers, and the plastics processing and metalworking industries. solvadis is one of the top three European companies in chemicals distribution. Although it operates internationally through the Chemworld Alliance together with U.S., U.K. and Asian partners, solvadis’ activities are mainly centered on Europe. Its Retailing unit markets liquid and solid elementary sulfur throughout northwestern Europe. Its customers include German gas producers and a number of oil companies that operate refineries in Europe. Apart from sulfur, solvadis also trades in methanol, a key basic commodity for the chemical industry. Global consumption is currently around 28 million tonnes per year, and is on the increase. solvadis expects to sell approximately 320,000 tonnes of methanol in 2004. Specialty mechanical engineering • Industrial plant engineering • mg chemical group Sales solvadis in s million 1,440.8 1,416.0 01/02 03 39
Page 1 and 2: “2003 was a year of transition fo
Page 3 and 4: Consolidated Key Figures 2003 RESUL
Page 5 and 6: Creating freedom for action CONTENT
Page 7 and 8: MANAGEMENT SHARE STRATEGY SPECIAL S
Page 25 and 26: zation As the world’s population
Page 33 and 34: The pharmaceutical industry will co
Page 37 and 38: Milk Last year, over 160 million co
Page 39 and 40: The MODUL tablet press produced by
Page 41: MANAGEMENT SHARE STRATEGY SPECIAL S
Page 45 and 46: For a technology-driven organizatio
Page 81 and 82: mg's mission is to ensure sustainab
Page 93 and 94:
MANAGEMENT SHARE STRATEGY SPECIAL S
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
MANAGEMENT AKTIE STRATEGIE SONDERTE
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185:
Key Figures for the mg Group RESULT
show all

E_mg_GB_03_vorne-29_3_04

Create successful ePaper yourself

Delete template?

Save as template?